We are live on ! Find out more
XENT

Intersect ENT, Inc
XENT

Delisted

XENT was delisted on the 12th of May, 2022.

Back to rankings

112 hedge funds and large institutions have $521M invested in Intersect ENT, Inc in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

430% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $3.05M

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

0% more funds holding

Funds holding: 112 → 112 (0)

0% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 20

25% less capital invested

Capital invested by funds: $690M → $521M (-$169M)

Holders
112
Holders Change
–
Holders Change %
0%
% of All Funds
2.46%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
20
Increased
44
Reduced
33
Closed
20
Calls
$16.1M
Puts
$3.05M
Net Calls
+$13.1M
Net Calls Change
+$2.12M

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$25.3M
2
BC
Broadfin Capital
New York
+$14.2M
3
FLAM
First Light Asset Management
Minnesota
+$9.96M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$7.28M
5
PVI
Pura Vida Investments
New York
+$6.54M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$31.5M
2
Millennium Management
Millennium Management
New York
-$16.2M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$7.98M
5
HM
HealthCor Management
New York
-$4.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
QCG
101
Quadrant Capital Group
Ohio
$36K +$39.1K +2,148 New
Zurich Cantonal Bank
102
Zurich Cantonal Bank
Switzerland
$35K – – –
SFSIG
103
San Francisco Sentry Investment Group
California
$26K – – –
S
104
SignatureFD
Georgia
$17K – – –
MAM
105
Meeder Asset Management
Ohio
$16K +$11.8K +648 +260%
TRCT
106
Tower Research Capital (TRC)
New York
$13K +$14.3K +787 New
AG
107
Advisor Group
Arizona
$8K +$2.44K +134 +38%
US Bancorp
108
US Bancorp
Minnesota
$8K +$5.79K +318 +182%
PCM
109
Prelude Capital Management
New York
$5K +$4.92K +270 New
IA
110
IFP Advisors
Florida
$2K +$1.82K +100 New
GT
111
Glenmede Trust
Pennsylvania
$2 – – –
Fidelity Investments
112
Fidelity Investments
Massachusetts
– -$11.9M -651,498 -100%
Thrivent Financial for Lutherans
113
Thrivent Financial for Lutherans
Minnesota
– -$3.82M -167,910 Closed
GLA
114
Great Lakes Advisors
Illinois
– -$2.27M -99,598 Closed
IBT
115
International Biotechnology Trust
United Kingdom
– -$2.18M -96,000 Closed
LOAMU
116
Lombard Odier Asset Management (USA)
New York
– -$2.05M -90,000 Closed
Renaissance Technologies
117
Renaissance Technologies
New York
– -$1.82M -80,200 Closed
OAM
118
Oxford Asset Management
United Kingdom
– -$963K -42,300 Closed
Squarepoint
119
Squarepoint
New York
– -$788K -34,639 Closed
JG
120
Jefferies Group
New York
– -$617K -27,124 Closed
First Trust Advisors
121
First Trust Advisors
Illinois
– -$556K -24,443 Closed
ARTA
122
A.R.T. Advisors
New York
– -$539K -23,677 Closed
SBH
123
Segall Bryant & Hamill
Illinois
– -$385K -16,935 Closed
Russell Investments Group
124
Russell Investments Group
United Kingdom
– -$269K -11,851 Closed
Canada Life
125
Canada Life
Manitoba, Canada
– -$91K -3,995 Closed
2 3 4
5
6

XENT Hedge Fund Activity: Q3 2019 in Review

112 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q3 2019, worth a combined $521M — down 25% from $690M a quarter earlier.

Fund positioning in XENT was balanced in Q3 2019: 20 funds opened new positions, 20 closed out, 44 added to existing stakes and 33 trimmed.

The largest buyer was UBS Group, adding an estimated $25.3M. The largest seller was Invesco, cutting an estimated $31.5M.

  • 112 institutional investors held Intersect ENT, Inc (XENT) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $521M of Intersect ENT, Inc stock for Q3 2019, down 25% quarter-over-quarter.
  • 20 funds opened new Intersect ENT, Inc positions in Q3 2019 and 20 closed out, a net change of 0 holders.
  • The largest Intersect ENT, Inc buyer in Q3 2019 was UBS Group, an estimated $25.3M added.
  • The largest Intersect ENT, Inc seller in Q3 2019 was Invesco, an estimated $31.5M sold.

Based on aggregated 13F filings for Q3 2019.